This article is more than 5 years old. Information may no longer be current.

VIDEO: Mouthwash reduces everolimus-related stomatitis in women with breast cancer

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN ANTONIO — A “miracle mouthwash” reduced stomatitis incidence during treatment with everolimus, Sharon Wilks, MD, FACP, oncologist with Texas Oncology, a practice in The U.S. Oncology Network, told HemOnc Today at the San Antonio Breast Cancer Symposium.

This treatment may help women with breast cancer stay on everolimus treatment longer and, thus, improve their outcomes.

“Now we have a drug that we can now use in women so it allows for us to have it as part of our active armamentarium — a mixture in a mouthwash that can really help women tolerate this common side effect to treatment,” she said. – by Kristie L. Kahl

Disclosure: Wilks report no relevant financial disclosures.